Finance

Beta
Lists
CELC:NASDAQ
Celcuity Inc
$90.37
+0.49%
(+0.44) 1D
Jun 23, 10:58:20 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CELC...
Open
$88.84
High
$91.04
Low
$87.88
Mkt. cap
4.39B
Avg. vol.
1.59M
Volume
143.94K
52-wk high
$151.02
52-wk low
$11.28
EPS
-$3.90
Beta
0.10
Shares outstanding
48.77M
No. of employees
155
Open
$88.84
High
$91.04
Low
$87.88
Mkt. cap
4.39B
Avg. vol.
1.59M
Volume
143.94K
52-wk high
$151.02
52-wk low
$11.28
EPS
-$3.90
Beta
0.10
Shares outstanding
48.77M
No. of employees
155
News stories
From sources across the web
About Celcuity Inc
CEO-
Employees155
Founded2011
HeadquartersMinneapolis, Minnesota, United States
SectorBiotechnology
Websitecelcuity.com
Analyst Ratings
Based on 9 analysts giving stock ratings to CELC in the past 3 months
Strong Buy
Buy
9
Hold
0
Sell
0
12 month forecast
Based on 9 Wall Street analysts offering 12 month price targets for CELC in the last 3 months.
Highest
Current $90.37
$175.00 (+93.64%)
Average
$163.00 (+80.36%)
Lowest
$145.00 (+60.44%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Chase Knickerbocker
Craig-Hallum
Buy
Reiterated
$171.00
+89.2%
06/03/2026
Bradley Canino
Guggenheim
Buy
Maintained
$165.00
+82.6%
06/03/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
$145.00
+60.4%
06/03/2026
Eva Fortea Verdejo
Wells Fargo
Buy
Reiterated
$166.00
+83.7%
06/03/2026
Gil Blum
Needham
Buy
Reiterated
$157.00
+73.7%
06/02/2026
Oliver McCammon
LifeSci Capital
Buy
Maintained
$165.00
+82.6%
06/02/2026
Stephen Willey
Stifel Nicolaus
Buy
Reiterated
$175.00
+93.6%
05/15/2026
Tara Bancroft
TD Cowen
Buy
Maintained
-
-
05/14/2026
Silvan Turkcan
Citizens JMP
Buy
Maintained
$160.00
+77%
05/04/2026
Unknown Analyst
Citizens JMP
Buy
Initiated
$150.00
+66%
04/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
40.22M
34.92M
37.31M
33.06M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.79M
7.93M
11.89M
17.44M
Operating expense
44.01M
42.85M
49.20M
50.51M
Total operating expenses
44.01M
42.85M
49.20M
50.51M
Operating income
-44.01M
-42.85M
-49.20M
-50.51M
Other non operating income
-
-
-
-
EBT including unusual items
-45.27M
-43.80M
-50.97M
-52.84M
EBT excluding unusual items
-45.27M
-43.80M
-50.97M
-52.84M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-45.27M
-43.80M
-50.97M
-52.84M
Net profit margin
-
-
-
-
Earnings per share
-0.93
-0.78
-0.73
-0.86
Interest and investment income
1.94M
3.64M
4.39M
3.75M
Interest expense
-3.20M
-4.60M
-6.17M
-6.08M
Net interest expenses
-1.26M
-955.00K
-1.77M
-2.33M
Depreciation and amortization charges
-
-
-
-
EBITDA
-43.97M
-42.81M
-49.15M
-50.46M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer